are there generic glp-1 drugs There's still no Ozempic, but a lower-priced daily injected is coming First Generic GLP-1 Injection OK'd
Description
Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

Common versions include tirzapetide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy/Rybelsus) and are available orally or subcutaneously (injections)

But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.
The list of conditions for which GLP-1 drugs provides benefit independent of weight loss keeps growing
GLP-1 2.0: where will the next wave of value come from

Explore the best alternatives to tirzepatide for weight loss, from semaglutide to retatrutide, compounded options, and natural approaches with data.
